e-learning
resources
Glasgow 2004
Monday 06.09.2004
SARS and other lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of cytokine and chemokine profiles in the development of the severe acute respiratory syndrome(SARS)
J. Xu, Y. Jiang, S. Zhong, C. Zhou, J. Liu, T. Cheng (Guangzhou, China)
Source:
Annual Congress 2004 - SARS and other lower respiratory tract infections
Session:
SARS and other lower respiratory tract infections
Session type:
Poster Discussion
Number:
1569
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Xu, Y. Jiang, S. Zhong, C. Zhou, J. Liu, T. Cheng (Guangzhou, China). Characterization of cytokine and chemokine profiles in the development of the severe acute respiratory syndrome(SARS). Eur Respir J 2004; 24: Suppl. 48, 1569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
High dimensional single cell analysis reveals unexpected immune cell types, and loss of motility and chemokine receptor expression of alveolar macrophages in chronic obstructive respiratory disease
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 132s
Year: 2007
Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
Differential gene expression and cytokine production from neutrophils in asthma phenotypes
Source: Eur Respir J 2010; 35: 522-531
Year: 2010
Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD.
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Characterization of the Toll-IL-1 pathway gene profile in an
in-vitro
model of chronic airway inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Expression of stress genes in circulating leucocytes: response to the systemic inflammation in patients with severe pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 231s
Year: 2004
YS1: Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Reduced chemokine responses in human neonatal cells upon infection with RSV.
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Eur Respir Rev 2006; 15: 207-208
Year: 2006
Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept